BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37273554)

  • 1. Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress.
    Shi S; Luo H; Ji Y; Ouyang H; Wang Z; Wang X; Hu R; Wang L; Wang Y; Xia J; Cheng B; Bao B; Li X; Liao G; Xu B
    Oxid Med Cell Longev; 2023; 2023():9595201. PubMed ID: 37273554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
    Zheng S; Wu R; Deng Y; Zhang Q
    Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial impairment and downregulation of Drp1 phosphorylation underlie the antiproliferative and proapoptotic effects of alantolactone on oral squamous cell carcinoma cells.
    Zhang Y; Yang B; Tu C; Ping Y; Chen S; Wu T; Zhao Z; Mao Y; Yang Z; Cao Z; Li J; Huang K; Ding X; Wu G; Zou P; Deng Z; Sun X
    J Transl Med; 2023 May; 21(1):328. PubMed ID: 37198593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of RNA polymerase I and mTORC1/2 synergize to combat oral squamous cell carcinoma.
    Shi S; Luo H; Wang L; Li H; Liang Y; Xia J; Wang Z; Cheng B; Huang L; Liao G; Xu B
    Biomed Pharmacother; 2021 Jan; 133():110906. PubMed ID: 33190037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Knockdown of Macrophage Migration Inhibitory Factor Enhances UVB Irradiation-Induced Apoptosis Via Increasing ROS Generation in Oral Squamous Cell Carcinoma.
    Chen T; Chen Q; Li F; Zeng M; Wang B; Huang S; Chen S; Tao Z
    Technol Cancer Res Treat; 2023; 22():15330338231163436. PubMed ID: 37272017
    [No Abstract]   [Full Text] [Related]  

  • 8. San-Zhong-Kui-Jian-Tang Exerts Antitumor Effects Associated With Decreased Cell Proliferation and Metastasis by Targeting ERK and the Epithelial-Mesenchymal Transition Pathway in Oral Cavity Squamous Cell Carcinoma.
    Hsu PY; Chen JL; Kuo SL; Wang WL; Jan FW; Yang SH; Yang CY
    Integr Cancer Ther; 2022; 21():15347354221134921. PubMed ID: 36404765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
    Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
    J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
    Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
    J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of reactive oxygen species by polyenylpyrroles derivatives causes DNA damage leading to G2/M arrest and apoptosis in human oral squamous cell carcinoma cells.
    Hua KF; Liao PC; Fang Z; Yang FL; Yang YL; Chen YL; Chiu YC; Liu ML; Lam Y; Wu SH
    PLoS One; 2013; 8(6):e67603. PubMed ID: 23840748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS.
    Li D; Kou Y; Gao Y; Liu S; Yang P; Hasegawa T; Su R; Guo J; Li M
    Aging (Albany NY); 2021 Jan; 13(3):4242-4257. PubMed ID: 33495407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoquinone potentiates anti-cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress.
    Fath MK; Nasiri K; Ghasemzadeh S; Nejati ST; Ghafari N; Masouleh SS; Dadgar E; Kazemi KS; Esfahaniani M
    Chem Biol Drug Des; 2024 Mar; 103(3):e14492. PubMed ID: 38485457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
    Chen L; Zhu Q; Lu L; Liu Y
    Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells.
    Liu JF; Chang TM; Chen PH; Lin JS; Tsai YJ; Wu HM; Lee CJ
    J Food Biochem; 2022 Nov; 46(11):e14221. PubMed ID: 35596593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic antimicrobial peptide NRC-03 induces oral squamous cell carcinoma cell apoptosis via CypD-mPTP axis-mediated mitochondrial oxidative stress.
    Hou D; Hu F; Mao Y; Yan L; Zhang Y; Zheng Z; Wu A; Forouzanfar T; Pathak JL; Wu G
    Redox Biol; 2022 Aug; 54():102355. PubMed ID: 35660629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucocalyxin A impairs tumor growth via amplification of the ATF4/CHOP/CHAC1 cascade in human oral squamous cell carcinoma.
    Wang X; He MJ; Chen XJ; Bai YT; Zhou G
    J Ethnopharmacol; 2022 May; 290():115100. PubMed ID: 35151835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pristimerin induces apoptosis and tumor inhibition of oral squamous cell carcinoma through activating ROS-dependent ER stress/Noxa pathway.
    Zhao Q; Cheng X; Yu W; Bi Y; Guo J; Ma Q; Gong Y; He L; Yu X
    Phytomedicine; 2021 Nov; 92():153723. PubMed ID: 34482221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
    Dawei H; Honggang D; Qian W
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.